期刊文献+

3p杂合性缺失与乳腺癌发生发展相关性的研究

Study of Relationship of 3p Allele Loss and Pathogenesis of Breast Cancer
暂未订购
导出
摘要 目的:探讨染色体3p区域多个等位基因位点的杂合性缺失(loss of heterozygos ity,LOH)与乳腺癌发生发展之间的相关性。方法:采用微切割技术和PCR-SSLP银染技术结合微卫星重复序列多态性,分析45例乳腺癌石蜡库存标本中3p25、3p22-24、3p21.3、3p21.2-21.3、3p14.3、3p14.2和3p12等多个位点的杂合性缺失(LOH)。结果:45例乳腺癌标本中的LOH检出率分别为3p25(48%)、3p22-24(61%)、3p21.3(69%)、3p21.2-21.3(58%)、3p14.3(41%)、3p14.2(45%)和3p12(35%),其中3p21.3区域LOH出现率最高(69%)。分析各3p位点LOH与临床分期、淋巴结转移和雌孕激素受体(ER、PR)的相关关系,发现3p25区的LOH与孕激素受体表达的缺失之间具有相关性(P=0.006);3p22-24区的LOH与乳腺癌临床分期之间具有相关性(P=0.009)。结论:通过联合检测染色体3p区域多个位点的LOH将有助于乳腺癌的诊断和判断患者的预后。 Objective:To investigate the frequency of loss of heterozygosity (LOH) at several 3p regions in breast cancer tissues. Methods:Forty-five archival, paraffin-embedded,surgically resected breast cancer specimens were studied. Precisely identified malignant and normal lymph node tissues were microdissected from stained slides and analyzed for allele loss using polymerase chain reaction-based assays for dinucleotide repeat polymorphisms at six chromosome 3p loci (3p25,3p22-24,3p21.3,3p21.2-21.3,3p14. 3,3p14. 2, and 3p12). Results:The 3p21.3 region had the highest frequency of LOH(67%), followed by 3p22-24(61%),3p21.2-21.3(58%) ,3p25(48%), 3p14. 2(45%) ,3p14. 3(41%), and 3p12 (35%). There was a statistically significant correlation between loss of progesterone receptor expression and LOH at 3p25 (P=0. 006) and poor clinical stage and LOH at 3p22-24 (P=0. 009). Conclusions:These findings suggest that the measurement of LOH at 3p may be an useful predicting marker for diagnosis and prognosis of patients with breast cancer.
出处 《中国误诊学杂志》 CAS 2007年第10期2184-2186,共3页 Chinese Journal of Misdiagnostics
基金 深圳市卫生科技计划攻关项目(编号:200405001 200204047)
关键词 乳腺肿瘤/遗传学 杂合子丢失 Breast neoplasms/genetics Loss of heterozygosityheterozygosity
  • 相关文献

参考文献8

  • 1Petursdottir TE,Hafsteinsdottir SH,Jonasson JG,et al.Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients[J].Anticancer Res,2002,22(6A):3205-3212.
  • 2Chmara M,Wozniak A,Ochman K,et al.Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer[J].Anticancer Res,2004,24(6):4259-4263.
  • 3Tomizawa Y,Kohno T,Kondo H,et al.Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma[J].Clin Cancer Res,2002,8(7):2362-2368.
  • 4Duncan RE,Archer MC.Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells[J].Biochem Biophys Res Commun,2006,343(1):239-243.
  • 5Bistulfi G,Pozzi S,Ren M,et al.A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation:implications for predicting breast cancer risk[J].Cancer Res,2006,66(21):10308-10314.
  • 6Zhao C,Lam EW,Sunters A,et al.Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer:regulation by methylation[J].Oncogene,2003,22(48):7600-7606.
  • 7Skliris GP,Munot K,Bell SM,et al.Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model[J].J Pathol,2003,201(2):213-220.
  • 8汤绚丽,姚根有,杨泽然,李世兰,陈丽荣.乳腺癌及癌前病变3号染色体短臂杂合性缺失的研究[J].中华外科杂志,2006,44(19):1314-1317. 被引量:6

二级参考文献7

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部